Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians
2008
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II)
2010
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
2011 Standout
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial
2011
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acromegaly
2006 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Biology of Langerhans Cells and Langerhans Cell Histiocytosis
2006
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
2005
Selection of Surgical or Percutaneous Coronary Intervention Provides Differential Longevity Benefit
2006
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase
2006
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Eosinophil function in health and disease
1995
Pathology of Drug-Eluting Stents in Humans
2006 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Routine Intraoperative Completion Angiography After Coronary Artery Bypass Grafting and 1-Stop Hybrid Revascularization
2009
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Physical characterization of controlled release of paclitaxel from the TAXUS™ Express2™ drug‐eluting stent
2004
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents
2006
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
2009
Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention with Drug‐Eluting Stent Implantation in Patients with Multivessel Coronary Disease
2007
Regulation of myeloid development and function by colony stimulating factors
2003
Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations
2009
Cellular survival: a play in three Akts
1999 Standout
Percutaneous Intervention Versus Coronary Bypass Surgery for Patients Older Than 70 Years of Age With High-Risk Unstable Angina
2005
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
2013
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Minimally Invasive Hybrid Coronary Artery Revascularization
2008
Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
2008
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease
2007
Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients
2010
A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery
2007
Real‐world use of the Impella 2.5 circulatory support system in complex high‐risk percutaneous coronary intervention: The USpella Registry
2011
Restenosis following implantation of bare metal coronary stents: Pathophysiology and pathways involved in the vascular response to injury
2006
The myelodysplastic syndrome.
1989
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
2013 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease.☆Insights from the SYNTAX run-in phase
2006
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Guidelines for Percutaneous Coronary Interventions
2005
Timing of In-Hospital Coronary Artery Bypass Graft Surgery for Non–ST-Segment Elevation Myocardial Infarction Patients
2010
Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease
2008
Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study
2011
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease
2008
Coronary revascularization in diabetic patients
2012
Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation
2005
5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions
2010
On the mechanisms of biocompatibility
2008 Standout
Comparison of Long-Term Outcome of Off-Pump Coronary Artery Bypass Grafting Versus Drug-Eluting Stents in Triple-Vessel Coronary Artery Disease
2011
Neutrophils in cancer: neutral no more
2016 Standout
Therapeutic potential of target of rapamycin inhibitors
2004
Coronary-Artery Stents
2006
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis
2004
The Effects of Paclitaxel on the Three Phases of Restenosis
2004
Same-Day Combined Percutaneous Coronary Intervention and Coronary Artery Surgery
2007
Assessment of Health-Related Quality of Life after Coronary Revascularization
2005
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages
1992
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Atom Transfer Radical Polymerization (ATRP): Current Status and Future Perspectives
2012 Standout
Long-Term Survival After Surgery Versus Percutaneous Intervention in Octogenarians With Multivessel Coronary Disease
2007
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease
2007
Mechanisms of tumor necrosis factor-granulocyte-macrophage colony- stimulating factor-induced dendritic cell development
1993
Long-Term Mortality After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease
2008
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Controlled/living radical polymerization: Features, developments, and perspectives
2007 Standout
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule–deficient mice
2001
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.
2006
Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease
2007
Comparing Long-Term Survival of Patients With Multivessel Coronary Disease After CABG or PCI
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions
2003
Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease
2008
Hematopoietic growth factors and their receptors in acute leukemia
1993
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients
2006
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Evaluation of Acrylate-Based Block Copolymers Prepared by Atom Transfer Radical Polymerization as Matrices for Paclitaxel Delivery from Coronary Stents
2005
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
2007
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Analysis of Signal Transduction Pathways in Human Eosinophils Activated by Chemoattractants and the T-Helper 2–Derived Cytokines Interleukin-4 and Interleukin-5
1998
Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease
2008
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
2008
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
The late asthmatic response is associated with baseline allergen‐specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin‐5
1999
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
2002
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Analysis of Signal Transduction Pathways in Human Eosinophils Activated by Chemoattractants and the T-Helper 2–Derived Cytokines Interleukin-4 and Interleukin-5
1998
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II)
2007
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Bianca Backx being referenced
Somatostatin and its cyclic octapeptide analog SMS 201–995 as inhibitors of proliferation of human acute lymphoblastic and acute myeloid leukemia
1995
Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
2005
Noninvasive Detection of Subclinical Coronary Atherosclerosis Coupled With Assessment of Changes in Plaque Characteristics Using Novel Invasive Imaging Modalities
2006
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions
2002
Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia
1993
Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors.
1991
Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia
1993
Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.
1990
Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome
1992
Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
2004
TAXUS III Trial
2003
Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
1996